Fitzgerald Thomas A 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-21 4:02 pm Purchase | 2024-06-14 | 13D | TransCode Therapeutics, Inc. RNAZ | Fitzgerald Thomas A | 12,789 5.500% | 12,789 (New Position) | Filing |